Ipca Laboratories Limited (IPCALAB): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Ipca Laboratories Limited, explained in plain English.

• ▪Ipca Laboratories Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪IPCALAB closed at ₹1,927.80 on 30 October 2026.
• ▪Over the past year the shares are up 49.6%, trading between ₹1,268.00 and ₹2,038.00.
• ▪Reported fundamentals show a net margin of 12.93%, debt to equity of 8.49.
• ▪Our transparent MaxGrade checklist scores it B (70/100) across momentum, growth, profitability and safety on fixed thresholds.
• ▪Annualised volatility over the past year is 30.32% with a maximum drawdown of -11.3%.
• ▪Recent coverage: Nifty Pharma index hits record high; Sun, Laurus, Zydus, Sai rally up to 6%
• ▪Recent coverage: Ipca Laboratories among 4 stocks showing RSI trending up

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 30 Oct 2026. Market closed.